Respiratory
Fascinating articles covering the respiration sector of the pharma industry, from research to new products and innovations.
Articles
Improving outcomes in idiopathic pulmonary fibrosis
Galecto tells Pharmafile about the benefits of inhaled technology to treat idiopathic pulmonary fibrosis
31 May 2022Respiratory
ROCK2 the top: the future of IPF therapeutics
RedX share their thoughts about the current and future treatments for idiopathic pulmonary fibrosis
31 May 2022Respiratory
Helping the world prepare for future pandemics
Pharmafile speaks to Open Orphan: Open Orphan tells Pharmafile about the respiratory disease landscape, as well as how human challenge trials may further understanding of the area
31 May 2022Respiratory
Dose and deliver: How PMDIs are transforming asthma and COPD treatments
Aptar Pharma discuss how PMDIs continue to change the landscape of asthma and COPD treatment
31 May 2022Respiratory
Pharmafile
Therapeutic areas in focus